Author:
Bellmunt Joaquim,Valderrama Begoña P.,Puente Javier,Grande Enrique,Bolós M. Victoria,Lainez Nuria,Vázquez Sergio,Maroto Pablo,Climent Miguel Ángel,Garcia del Muro Xavier,Arranz José Ángel,Durán Ignacio
Reference134 articles.
1. Neoadjuvant chemotherapy in invasive bladder cancer: update of a systematic review and meta-analysis of individual patient data advanced bladder cancer (ABC) meta-analysis collaboration;Advanced Bladder Cancer (ABC) Meta-analysis Collaboration;Eur. Urol.,2005
2. Overall survival, costs, and healthcare resource use by line of therapy in medicare patients with newly diagnosed metastatic urothelial carcinoma;Aly;J. Med. Econ.,2019
3. Avelumab, an anti-programmed death-ligand 1 antibody, in patients with refractory metastatic urothelial carcinoma: Results from a multicenter, phase ib study;Apolo;J. Clin. Oncol.,2017
4. Chapter 197 - tumors of the kidney, bladder, ureters, and renal pelvis;Bajorin,2016
5. Adjuvant nivolumab versus placebo in muscle-invasive urothelial carcinoma;Bajorin;New Engl. J. Med.,2021
Cited by
17 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献